DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

Sanofi (ADR) (NYSE: SNY)

48.29 0.20 (0.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SNY $48.29 0.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.16
Previous Close $48.09
Daily Range $48.15 - $48.48
52-Week Range $44.50 - $57.42
Market Cap $127.6B
P/E Ratio 25.85
Dividend (Yield) $1.91 (2.7%)
Ex-Dividend Date
Dividend Pay Date
Volume 565,469
Average Daily Volume 3,424,408
Current FY EPS $3.25





Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website:

News & Commentary

Should Gilead Sciences, Inc. Pay a Dividend?

Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?

MannKind: The Newest Bear Talking Point Is Absurd

Keryx Biopharmaceuticals: 40% Upside In The Bear Case

Best Idea For 2014: Sanofi Rights Post-FDA Approval

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs

Will Insulin Pricing Be MannKind Corporation's Downfall?

MannKind marketing partner Sanofi had to discount its Lantus insulin to get insurers to cover the drug.

Health Care Sector Update for 11/25/2014: NERV,DSKX,MDGN

Should MannKind's Shareholders Buy Al Mann's New Company?

Three Motley Fool analysts give their thoughts on whether or not to buy Al Mann's Second Sight on its initial public offering.

Sanofi's (SNY) Cerdelga a Step Closer to European Approval - Analyst Blog

Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year

Gilead's newly acquired priority review voucher is useful, but requires the biotech to give the FDA a 365-day warning that it's going to use the voucher.

See More SNY News...

SNY's Top Competitors

SNY $48.29 (0.42%)
Current stock: SNY
JNJ $108.25 (0.97%)
Current stock: JNJ
MRK $60.40 (1.09%)
Current stock: MRK
GSK $46.45 (-0.15%)
Current stock: GSK